MedPath
NMPA Approval

Levodopa and Benserazide Hydrochloride Tablets

国药准字H10930198

July 2, 2024

Drug Information

多巴丝肼片

美多芭

美多芭

片剂

左旋多巴200mg与苄丝肼50mg(相当于盐酸苄丝肼57mg)

化学药品

July 2, 2024

Company Information

Applicant Company

中国(上海)自由贸易试验区龙东大道1100号

Manufacturing Company

山东省淄博市高新区鲁泰大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多巴丝肼片 - NMPA 批准文号 | MedPath